Unexplained weight loss (UWL), defined as a loss of 5% or more of total body weight within a six-month period, is a common but challenging diagnostic dilemma in clinical practice. This article aims to provide a comprehensive approach to the evaluation of unexplained weight loss.
UWL can be the result of various underlying conditions, ranging from malignancy, gastrointestinal disorders, endocrine abnormalities, to psychiatric disorders. In some cases, despite extensive evaluation, no cause is found, leading to a diagnosis of idiopathic UWL.
The first step in the evaluation of UWL is a detailed history and physical examination. Key elements to be elicited include the time course of weight loss, associated symptoms, dietary history, medication use, and psychosocial history. A thorough physical examination can also provide clues to the underlying etiology.
If the history and physical examination do not reveal a cause, further investigations are warranted. Basic laboratory tests, including complete blood count, comprehensive metabolic panel, thyroid function tests, and urinalysis, should be performed. Imaging studies, such as chest radiography and abdominal ultrasonography, may also be considered based on the clinical suspicion.
The management of UWL is primarily directed towards the underlying cause. In cases of idiopathic UWL, the focus should be on symptom management and regular monitoring for the emergence of new symptoms or signs that may point to an underlying disease.
UWL is a complex clinical problem that requires a systematic and comprehensive approach. A thorough history and physical examination, followed by targeted laboratory and imaging investigations, form the cornerstone of evaluation. Management is etiology-specific, with idiopathic cases requiring careful monitoring and supportive care.
1.
Oncologist Sued for Double-Billing; Pharmacy Deserts; 'She Loved Scotch and Pizza'
2.
Renewing the call for a national Cancer Patient's Bill of Rights
3.
Woman Loses 6-Year Battle With Mouth Tumor
4.
Pressing the Sleep button could have a positive impact on cognition.
5.
FDA Approves Iberdomide Combo for Multiple Myeloma
1.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
2.
HPV and Immunotherapy in Cancer Survivorship: National Cancer Survivors Day Review
3.
Polycythemia Vera: A Historical Perspective and Contemporary Management
4.
ctDNA in Aggressive B-Cell Lymphoma: Redefining MRD and Prognostic Monitoring
5.
Prevention Through Survivorship-Focused Strategies for Preserving Functional Independence After Cancer
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
2.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
3.
The Role of Platelets in Normal Blood Clotting
4.
Comprehensive Update on Hematology
5.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation